The anti-lymphoma activities of anti-CD137 monoclonal antibodies are enhanced in FcγRIII−/− mice

Michelle A. Sallin(University of Maryland, Baltimore), Scott E. Strome(Northwestern Medicine Lake Forest Hospital), Erin Burch(Syngenta (United States)), Xiaoyu Zhang(Agilent Technologies (United States)), Edward So(University of Maryland, Baltimore), Andrei I. Chapoval(Human Genome Sciences (United States)), Wei Lin(Fujian University of Traditional Chinese Medicine), Ling Cai(The University of Texas Southwestern Medical Center)
Cancer Immunology Immunotherapy
June 13, 2014
Cited by 5


Related Papers